About: Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal ("GI") tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.43 (-3.15%)
ONCY NASDAQ Oncolytics Biotech Inc
Oncolytics Biotech Inc share price
Atividade de preço de ONCY
Último preço
$ 0,430
Variação (24h)
-0,01 USD (3,15%)
Volume
603.17K
Volume (média 4 sem.)
-
Abertura
$ 0,44
Variação do dia
$ 0,43 - $ 0,45
Fechamento anterior
$ 0,44
Último negócio
29 Oct, 8:29 pm GMT+0
Atrasado
29 Oct, 8:29 pm GMT+0
ONCY price performance
Atrasado
29 Oct, 8:29 pm GMT+0
quote.marketSignals